Successful lipid-complexed amphotericin B treatment of Candida arthritis in a lymphoma patient.

No abstract is available for this paper.

• Publication year

  1999

• Venue

  Revue du rhumatisme

• Publication date

  1999-07-01

• Fields of study

  Medicine

• Identifiers
  PMID 10526387
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Liposomal amphotericin B for empirical therapy in patients with persistent fever and neutropenia. National Institute of Allergy and Infectious Diseases Mycoses Study Group.

  1999cited by this paper
• The use of liposomal amphotericin B in the treatment of neutropenia‐associated fungal infections: efficacy and cost‐effectiveness

  1999cited by this paper
• Role of the new azoles in the treatment of fungal osteoarticular infections.

  1998cited by this paper
• Liposomal amphotericin B compared with amphotericin B deoxycholate in the treatment of documented and suspected neutropenia‐associated invasive fungal infections

  1998cited by this paper
• A randomized comparison of liposomal versus conventional amphotericin B for the treatment of pyrexia of unknown origin in neutropenic patients

  1997cited by this paper
• Candida tropicalis arthritis in a patient with acute myeloid leukemia successfully treated with fluconazole: Case report and review of the literature

  1997cited by this paper
• Multifocal osteoarthritis due toCandida albicans in a neonate: Serum level monitoring of liposomal amphotericin B and literature review

  1997cited by this paper
• Clinical use of liposomal and lipid-complexed amphotericin B.

  1994cited by this paper
• Candida arthritis in adult patients who are not intravenous drug addicts: report of three cases and review of the literature.

  1993cited by this paper
• Fungal arthritis.

  1992cited by this paper

• Osteoarticular Mycoses

  2022cites this paper
• Aster yomena has anti-arthritic activity against septic arthritis induced by Candida albicans: its terpenoid constituent is the most effective and has synergy with indomethacin

  2019cites this paper
• Long-term sustained-released in situ gels of a water-insoluble drug amphotericin B for mycotic arthritis intra-articular administration: preparation, in vitro and in vivo evaluation

  2015influential citation
• Candida Arthritis: Analysis of 112 Pediatric and Adult Cases

  2015cites this paper
• The potential of plant extracts against multidrug resistant Candida species-A review

  2015cites this paper
• Effect of Chamomile Flower Extract on Septic Arthritis due to Candida albicans

  2014cites this paper
• Candida krusei arthritis in a boy with acute lymphoblastic leukemia

  2013cites this paper
• Anti-inflammatory Effect of Paeoniflorigenone Isolated from Paeoniae Radix

  2012cites this paper
• Mucocutaneous and Deeply Invasive Candidiasis

  2011cites this paper
• Antiarthritic effect of lonicerin on Candida albicans arthritis in mice

  2011cites this paper
• Involvement of T-cell immunoregulation by ochnaflavone in therapeutic effect on fungal arthritis due to Candida albicans

  2011cites this paper
• Spondylodiscites à Candida spp.

  2010cites this paper
• Rutin has therapeutic effect on septic arthritis caused by Candida albicans.

  2009cites this paper
• Chlorogenic acid, a polyphenolic compound, treats mice with septic arthritis caused by Candida albicans.

  2008cites this paper
• Ginkgo terpene component has an anti-inflammatory effect on Candida albicans-caused arthritic inflammation.

  2005cites this paper
• Caspofungin as treatment for Candida glabrata hip infection.

  2005cites this paper
• Candida arthritis in a patient with chronic myelogenous leukemia (CML) in blastic transformation, unresponsive to fluconazole, but treated effectively with liposomal amphotericin B

  2002cites this paper
• Artrite fúngica: análise secundária de dados*

  2002cites this paper